Strides Shasun gets USFDA nod for nausea drug

Pharmaceutical company Strides Shasun said it received approval from the United States Food & Drug Administration to sell nausea drug Promethazine Hydrochloride in the country.

The US market for Promethazine Hydrochloride tablets is approximately USD 17 Million.

It will be sold in three doses ranging from 12.5 mg to 50 mg.

Promethazine Hydrochloride Tablet is used to prevent and treat nausea and vomiting related to certain conditions. It is also used to treat allergy Symptoms such as rash, itching, and runny nose.

It will be manufactured at the Company’s flagship facility at Bangalore and marketed by Strides Pharma Inc. in the US Market.

Strides Shasun, headquartered in Bangalore, has 8 manufacturing facilities spread across three continents including 6 US FDA approved facilities and 2 facilities for the emerging markets.

It has three R&D facilities in India and commercial operations in 85 countries.